CE IVD real-time PCR kit for detection of DPYD gene polymorphisms (*2A, *13, HapB3, c2846A>T) in human genomic DNA. Enables pharmacogenetic testing to guide dihydropyrimidine dehydrogenase deficiency screening and personalized drug dosing according to CPIC and DPWG guidelines. Uses fluorescently lab...
Manufactured by
Hradec Králové - Pražské Předměstí, Czech Republic
GENERI BIOTECH s.r.o. is a Czech biotechnological company focused on research and development, manufacturing and selling of own proprietary products: the CE IVD kits based on molecular genetic methods, Life Sciences products and Oligonucleotides. In addition, GENERI BIOTECH s.r.o. also run testing facilities for both public and GLP/GMP tests, typically for CROs in the field of drug development. GENERI BIOTECH s.r.o. was established in 1995, originally as a facility for production of oligonucleotides. The synthesis of oligonucleotides has long been the basis of the company's activities. Since 2010, however, in addition to oligo synthesis, we have also focused on the development and production of our own IVD kits and products for Life Science. Since then, our IVD portfolio has been growing steadily, covering not only hematological diagnostics, but also pharmacogenetics, genetics, microbiology and oncology, within the market segment of laboratory diagnostics in human medicine. The production at GB is certified according to IVDR Regulation (EU) 2017/746 of the European Parliament and of the Council ( in vitro diagnostics), EN ISO 13485:2016 ( in vitro diagnostics) and EN ISO 9001:2016 (oligonucleotides and life science products).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
TRUPCR Europe Ltd
United Kingdom · 2 relevant products
Blackhills Diagnostic Resources, S.L.U. BDR
Spain · 5 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
Coyote Bioscience Co.,Ltd
China · 5 relevant products
Shenzhen Uni-medica Technology Co., Ltd
China · 2 relevant products
LYTECH
Serbia · 2 relevant products
Daan Gene Co., Ltd.
China · 7 relevant products
HymonBio Co., Ltd.
China · 5 relevant products
Shenzhen HaploX Biotechnology Co., Ltd.
China · 1 relevant product
Atom Scientific Ltd
United Kingdom · 1 relevant product
43 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
TRUPCR Europe Ltd · United Kingdom
A molecular diagnostic kit for DPYD mutation detection. Used in pharmacogenomics and oncology for identifying dihydropyrimidine dehydrogenase gene mutations.
Blackhills Diagnostic Resources, S.L.U. BDR · Spain
Kit for multiplex detection of the variants c.1905+1G>A (rs3918290), c.1679T>G (rs55886062), c.1129-5923C>G (rs75017182), c.2846A>T (rs67376798), c.1236G>A (rs56038477), c.557A>G (rs115232898), c.868A>G (rs146356975) and c.2279C>T (rs112766203) of DPYD gene by Real-Time PCR using hydrolysis probes technology. This comprehensive kit detects multiple variants in the dihydropyrimidine dehydrogenase gene for pharmacogenetic testing.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Specialized gene detection kit for analyzing CYP2D6 genetic variations to predict drug metabolism and response. This test enables precision medicine by guiding drug selection and dosing for individual patients.
Coyote Bioscience Co.,Ltd · China
A molecular diagnostics reagent kit for human CYP2C19 gene typing using PCR with fluorescent probes. The kit supports pharmacogenetic testing for personalized medicine applications.
Shenzhen Uni-medica Technology Co., Ltd · China
A diagnostic kit for detecting CYP2C19 gene polymorphisms in human samples to guide personalized medication therapy.
LYTECH · Serbia
Genetic polymorphism detection kits for identifying genetic variations associated with drug metabolism, disease susceptibility, and therapeutic response. These in vitro diagnostic kits enable clinicians to personalize treatment decisions based on individual genetic profiles, supporting pharmacogenomics and precision medicine applications in clinical laboratories.
Coyote Bioscience Co.,Ltd · China
A gene genotyping detection kit for human CYP2C19 gene analysis using PCR with fluorescent probe methodology. It supports pharmacogenetic testing for precision medicine applications. Available variants: Human CYP2C19 Gene Genotyping Detection Kit (PCR Fluorescent Probe Method).
Daan Gene Co., Ltd. · China
PCR-based molecular diagnostic kit for genetic disease detection and identification. Utilizes polymerase chain reaction technology for accurate nucleic acid analysis.
Shenzhen Uni-medica Technology Co., Ltd · China
A diagnostic kit for genotyping of the human CYP2C19 gene.
HymonBio Co., Ltd. · China
In vitro diagnostic kit for detecting metabolic enzyme gene polymorphisms to assess individual drug metabolism capacity and guide personalized medication therapy. Uses molecular analysis to identify genetic variants affecting cytochrome P450 and other metabolic enzymes, enabling clinicians to optimize drug selection and dosing based on patient pharmacogenetic profiles.
Shenzhen HaploX Biotechnology Co., Ltd. · China
A genetic diagnostic test for detecting homologous recombination deficiency (HRD) status in cancer patients. This test is used to assess treatment options and prognosis in tumors with HRD signatures.
HymonBio Co., Ltd. · China
In vitro diagnostic kit for detecting clopidogrel-resistance gene polymorphisms to guide antiplatelet therapy decisions. Uses molecular analysis to identify genetic variants affecting clopidogrel metabolism in patients at risk of thrombotic events. Enables personalized treatment selection and dosing optimization for improved clinical outcomes.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products